MOH — authorised 1 February 2023
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: likely_approved
MOH authorised Jesduvroq on 1 February 2023
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 1 February 2023.
GLAXOSMITHKLINE holds the UAE marketing authorisation.